Medicis Pharmaceutical Corp. (MRX) Tops Q1 EPS by 10c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $76.05 +2.23%
Revenue Growth %: +21.2%
Financial Fact:
Diluted net income (loss) per share - continuing operations: 0.02
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +21.2%
Financial Fact:
Diluted net income (loss) per share - continuing operations: 0.02
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q1 EPS of $1.48, $0.10 better than the analyst estimate of $1.38. Revenue for the quarter came in at $692.3 million versus the consensus estimate of $686.37 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mosaic (MOS), Others Lower Following Trump Post on Potash from Belarus
- Trump: Will rein things in if we have to, but I will only encourage AI
- Saudi Aramco boosts crude loadings after pipeline disruption
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
